|
HS Code |
864945 |
| Generic Name | Fenofibrate |
| Brand Names | Tricor, Antara, Lipofen, Fenoglide |
| Drug Class | Fibrate |
| Indication | Hypercholesterolemia, hypertriglyceridemia |
| Dosage Form | Tablet, capsule |
| Route Of Administration | Oral |
| Mechanism Of Action | Activates peroxisome proliferator-activated receptor alpha (PPARα) |
| Common Side Effects | Headache, back pain, increased liver enzymes |
| Contraindications | Severe liver disease, severe kidney disease, gallbladder disease |
| Prescription Status | Prescription only |
| Metabolism | Primarily hepatic |
| Elimination Half Life | 20 hours |
| Storage Conditions | Store at room temperature, away from moisture and heat |
As an accredited Fenofibrate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Fenofibrate packaging: White, opaque plastic bottle containing 100 tablets, each 160 mg, with tamper-evident seal and clear labeling. |
| Shipping | Fenofibrate is typically shipped as a stable, solid powder or in tablet form, packaged in tightly sealed containers to protect from moisture and light. It is transported at ambient temperature with standard precautions and clear hazard labeling. The shipment complies with all relevant chemical safety and regulatory guidelines. |
| Storage | Fenofibrate should be stored in a tightly closed container at room temperature, ideally between 20°C to 25°C (68°F to 77°F). Keep it away from moisture, heat, and direct light. Store in a dry place and do not refrigerate or freeze. Ensure the medication is out of reach of children and pets, and dispose of it properly if expired. |
|
Purity 99%: Fenofibrate with Purity 99% is used in oral cardiovascular drug formulations, where it ensures consistent lipid-lowering efficacy. Particle Size <50 μm: Fenofibrate with Particle Size <50 μm is used in microgranule tablet production, where it improves dissolution rate and bioavailability. Melting Point 80°C: Fenofibrate with Melting Point 80°C is used in controlled-release matrix systems, where it maintains structural stability during processing. Stability Temperature 25°C: Fenofibrate with Stability Temperature 25°C is used in long-term pharmaceutical storage, where it provides extended shelf life and potency retention. Moisture Content <0.5%: Fenofibrate with Moisture Content <0.5% is used in capsule filling operations, where it prevents degradation and ensures uniform dosage. Assay ≥98.5%: Fenofibrate with Assay ≥98.5% is used in high-purity active pharmaceutical ingredient manufacturing, where it guarantees reliable therapeutic outcomes. Polymorph Form I: Fenofibrate with Polymorph Form I is used in solid oral dosage forms, where it delivers optimal solubility and absorption profiles. Residual Solvent <0.01%: Fenofibrate with Residual Solvent <0.01% is used in GMP-compliant drug production, where it meets regulatory safety standards. Bulk Density 0.4 g/cm³: Fenofibrate with Bulk Density 0.4 g/cm³ is used in powder blending processes, where it ensures accurate mixing and uniformity. Heavy Metals <5 ppm: Fenofibrate with Heavy Metals <5 ppm is used in pharmaceutical synthesis, where it minimizes toxicological risks for patients. |
Competitive Fenofibrate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Fenofibrate shows up across pharmacies as a prescription answer for high triglycerides and cholesterol. Many folks struggle with high cholesterol, sometimes because diabetes crept into their lives, sometimes because of less-than-perfect family genetics, and sometimes for reasons that just don’t seem fair. Fenofibrate, sold under brand names like Tricor, uses a straightforward plan: lower the blood’s bad fats while encouraging the good ones. From my own experience in medicine and weaving through conversations with patients who’ve seen it help where statins fall short, Fenofibrate makes a real difference as a second line or add-on after diet, exercise, or popular statins leave the job unfinished.
Doctors often explain that Fenofibrate works through the liver. Rather than wrestling cholesterol directly, it wakes up enzymes that help clear out fats from the bloodstream. The drug comes in a variety of tablet strengths and sometimes as capsules, which gives doctors flexibility. Doses can range and depend on the formulation the pharmacy stocks or what insurance is willing to cover—a constant, real-world frustration that shapes so much more of healthcare than many realize. Pharmacists and prescribers lean on regular lab checks since liver numbers and muscle health can shift once Fenofibrate gets involved. Not everyone on cholesterol medicine lands with muscle pain, but those who do after trying statins often ask about alternatives, and this is where Fenofibrate can step in.
Lots of people recognize statins—names like atorvastatin and simvastatin roll off the tongue. Those doctors consider statins the gold standard because strong studies show they cut the risk of heart attack or stroke. Fenofibrate treats a different crowd: people whose cholesterol pattern doesn’t fit the classic mold, especially those with high triglycerides rather than sky-high LDL (the “bad” cholesterol). People with diabetes often carry this pattern, with triglycerides stubbornly high and HDL (the “good” cholesterol) trailing low. Fenofibrate tackles this head-on. Anyone who watched a friend, parent, or themselves deal with the unpredictable swings in cholesterol panels will understand the relief Fenofibrate can bring.
Compared to niacin and fish oil, other options doctors have for changing blood fat numbers, Fenofibrate stands out for its targeted action and fewer issues around blood sugar swings or skin flushing. Not every patient wants to add niacin because of how it sometimes causes uncomfortable flushing or headaches, especially at higher doses. Fish oil supplements can be unwieldy, requiring many large capsules a day for any real effect, and they sometimes leave a lingering aftertaste. Fenofibrate fits into already busy routines since it’s usually a convenient, once-daily tablet. Some doctors pair it with a statin, but only in select cases—using both can raise the risk of muscle problems, so careful monitoring matters.
Fenofibrate hits the market in tablet and capsule forms, and the strength offered ranges widely. This variety lets doctors tailor medicine to meet each patient's bloodwork and risk factors. Some tablets offer 48 mg, others 145 mg, and extended-release options have smoothed out rough patches for people who don’t like abrupt spikes and drops. Extended-release formats have always felt like a small comfort: patients don’t complain about stomach issues as much, and it suits busy schedules.
Not every model is interchangeable, even when the milligrams match on paper—anyone who’s ever switched brands at the pharmacy will remember being told not to crush or chew different forms. Pharmacies may switch between generic versions, but pharmacists reliably double-check that insurance, doctor, and patient are all clear on how the pill should be taken. Swapping out one type for another mid-course doesn’t always go smoothly, and some patients find their lab numbers drift or their stomach doesn’t agree with the change. This is why the prescribing team chooses a specific formulation: sometimes a small tweak like this makes a big difference.
It’s important to clear up that cholesterol numbers never tell the whole story. After years spent watching lab work come back, I can say confidently that numbers alone don’t reflect family background, diet, exercise habits, or stress levels. Fenofibrate isn’t a miracle answer; results rely heavily on keeping up with lifestyle changes. Many patients want to believe that a pill erases the need for healthy eating or going for a walk, but true change happens with a mix of medication, meal planning, and sometimes sweating a little. Fenofibrate plays its part here, but it doesn’t do the heavy lifting alone.
One undervalued but critical strength is Fenofibrate’s relationship with blood sugar. For people fighting type 2 diabetes, balancing cholesterol and glucose can feel like chasing two rabbits at once. Statins occasionally nudge blood sugar higher—modest but sometimes worrisome for people already watching their numbers. Fenofibrate typically does not push glucose levels around, which comes as a relief to many diabetes patients already struggling to juggle finger sticks, insulin, or pills.
Side effects raise concerns with any prescription. No medicine comes without trade-offs, and Fenofibrate’s most visible ones appear on routine bloodwork. Elevated liver numbers—sometimes meaningful, sometimes minor—lead to extra follow-up visits and the occasional tough decision: stop now, or wait and see? For a small group, muscle aches arrive, especially for those with a history of trouble when statins were tried. The risk doesn’t quite match what’s seen with statins, but it can’t be ignored. Kidney function deserves respect as well. Fenofibrate may put extra work on the kidneys; older adults and anyone with chronic kidney disease must watch for small warning signs—a sudden change in creatinine, for example, or swelling.
Doctors can’t always predict who will do well on Fenofibrate. Those who tolerate it and combine it with steady habits see solid progress over time. But some patients struggle with pill fatigue, having to remember another tablet, or the cost of branded formulations when insurance coverage runs thin. Pharmacy copays vary wildly—some patients spend a little, and others get hit hard. Cost stands out as an unspoken reason why some people drift away from continued therapy, a challenge with every chronic disease treatment but especially so with cholesterol medicines that don’t make a person feel better day-to-day.
Newer cholesterol drugs have entered the market, like PCSK9 inhibitors. These products make headlines because they use antibodies to sweep LDL cholesterol away through entirely different pathways than Fenofibrate. But not every patient is a candidate. PCSK9 inhibitors usually treat people with extremely high cholesterol or strong family risk where nothing else works, and their cost sits multiple times higher than Fenofibrate in tablet form. Insurance roadblocks and prior authorizations often slow things down, sometimes for weeks. Realistically, most patients with moderate cholesterol elevation land on medicines like Fenofibrate or statins because they’re familiar, time-tested, and widely available.
I’ve heard stories in the clinic—frustration with how slow progress feels, hope for something more powerful, and honest talk about barriers to these new, shiny drugs. Fenofibrate continues to fill an important gap, especially for those who can’t tolerate statins or who don’t get enough triglyceride control from dietary changes and fish oil alone. Fenofibrate remains the go-to tool before more complex or expensive treatments get a try.
No medicine transforms health by itself. Fenofibrate plugs a specific hole in the world of cholesterol care, but no one should think a pill erases years of habits overnight. Real progress at the population level—fewer heart attacks, fewer trips to the hospital, longer lives—always depends on a mixture of smart medication use and daily choices. Patients who actively combine Fenofibrate with walking, healthy eating, cutting down on alcohol, and regular check-ups reap far greater benefits than those who use medication without any changes elsewhere.
Family support goes further than any pamphlet in the doctor’s office. Watching parents, siblings, or friends deal with the aftermath of a heart attack motivates change in ways numbers and graphs can’t. I’ve seen grandfathers decide to finally add in cholesterol medicine after seeing grandkids for the first time, or parents double down on exercise after a routine screening caught a problem. Fenofibrate becomes another tool in these long-running stories, useful because it slides into life with little extra hassle.
Not every region or community enjoys the same access to care. Rural clinics, overbooked urban health centers, and pharmacies without steady supply chains feel the effects firsthand. Fenofibrate’s place in the market often comes from its wide availability and proven safety record. Unlike some of the newer injectable medications, Fenofibrate rarely faces the same shortages. Yet, there’s still pressure from insurance companies, changes in generics, and periodic recalls or manufacturing hiccups. These real-world barriers matter. When insurance suddenly blocks a patient’s refills by requiring extra paperwork, blood fats spike, and frustration rises on every side. Lowering these hurdles—making sure patients can get continuity of care—matters every bit as much as inventing new products.
Education lags as well. Many times I’ve seen patients with high triglycerides who were never told about Fenofibrate. Public health campaigns usually focus on LDL, the “bad cholesterol,” because decades of research put it front and center. Patients in the know—usually because a family member lived through a cholesterol crisis—ask about the full panel, but most have never even heard about how triglycerides fit in. Getting the word out matters just as much as writing the right prescription. Doctors and clinics who talk with patients about specific options like Fenofibrate create opportunities for better targeted care.
Communities with more coordinated healthcare teams find better outcomes. Pharmacists and nurses who keep in touch with patients, answer questions about side effects, and recheck labs after a prescription change help close the loop. Electronic reminders and online support groups give patients the nudge they need to check on refills or ask for advice. Fenofibrate benefits from this teamwork because blood work guides its use. People do best when results get checked and discussed, not just filed away.
Healthcare systems that lower medication costs see more patients stick with therapy long enough to see improvements. Generic Fenofibrate tablets cost less than many alternatives, but insurance hiccups sometimes block patients anyway. Easing red tape, giving doctors the freedom to prescribe without jumping through endless authorization hoops, and pushing for fair prices help everyone—especially those living paycheck to paycheck. I’ve seen a patient cut pills in half to stretch out supply, and in that moment, it’s clear why just having the option isn’t enough. Solutions must also fit real-life budgets and routines.
Patient education makes a huge difference. Clear, small steps—like simply going over how Fenofibrate is taken, how long it takes to see results, and why follow-up bloodwork matters—build confidence. Some patients feel lost after being handed a bottle with dense printouts covered in warnings, so clinics that spend extra time answering questions and breaking down instructions see fewer mistakes. Useful, reliable education must move past clinical jargon and plug into how people really talk about their health.
When patients know what to watch for, they help spot trouble earlier. Muscle aches may just be a coincidence, or they could be early signals that a medicine adjustment is needed. Fenofibrate’s story stands out because patients can play an active role—asking about changes in urine output, reminding families to keep an eye on swelling, or reporting how their routine changes with new medicine. Doctors, nurses, and pharmacists must listen just as much as they teach. A team approach keeps side effects manageable and lets patients feel heard.
Research into new uses for Fenofibrate continues. Some studies look at whether it can reduce complications from diabetes beyond blood fats, or even play a role in reducing inflammation. These possible benefits come from real science, not just marketing. Payers and health administrators will keep an eye on this. If Fenofibrate proves itself across more situations, it will likely remain a staple—affordable and accessible for the majority.
Cholesterol can seem like an academic measure for many until something happens—a test result, a scare in the family, or a new diagnosis. Fenofibrate gives patients a reliable option when standard answers don’t fit, or when several health issues pile up and complicate the picture. Its long history means the surprises are fewer, and patients can slot it into their daily routines. Doctors who take a little extra time to match the right medicine with the right person find Fenofibrate’s place with ease.
From a practical standpoint, broader awareness about Fenofibrate and how it helps encourage the next wave of smarter care. Many people still think cholesterol treatment starts and ends with statins, but the world is broader. With higher rates of diabetes and metabolic syndrome in busy modern lives, the demand for medications like Fenofibrate will likely climb. As people get older, juggle more responsibilities, and try to hang onto good health through busy decades, practical tools like this one matter more than ever.
Fenofibrate’s role may not spark headlines, but it drives steady change in heart health for many. Fewer cholesterol-related trips to the hospital, more consistent quality of life, and better long-term confidence in one’s health add up across families and communities. Whether it’s a routine checkup or a major health scare, medicines like Fenofibrate keep options open, helping people steer their health back on course—one decision at a time.